Given Imaging Receives FDA Clearance for Next Generation PillCam(R) SB 3

GP20 says: Will this make it easier to develop generic GI products?

Improved PillCam SB Technology Provides a More Detailed and Efficient Small Bowel Examination for Patients With Conditions Such as Crohn’s Disease and Obscure GI Bleeding YOQNEAM, Israel, Aug. 13, 2013 (GLOBE NEWSWIRE) — Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and the pioneer of capsule endoscopy, today announced that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for the next generation PillCam, SB 3, to detect and monitor small bowel abnormalities associated with Crohn’s disease, obscure gastrointestinal (GI) bleeding and iron deficiency anemia.

Read the source article at